Showing results (141-150 of 178) with videos related to
Sort By:
Pageof 18
Annals of Medicine|January 25, 2011
Rheumatic heart disease and risk of incident heart failure among community-dwelling older adults: a prospective cohort studyMarjan Mujib, Ravi V Desai, Mustafa I Ahmed, et al.The American Journal of Medicine|October 3, 2020
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and HypertensionCharles Faselis, Phillip H Lam, Michael R Zile, et al.The American Journal of Medicine|November 22, 2013
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failureAli Ahmed, Robert C Bourge, Gregg C Fonarow, et al.Journal of the American Medical Directors Association|May 15, 2017
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart FailureHelen M Sheriff, Manik R Thogaripally, Gurusher Panjrath, et al.The American Journal of Cardiology|April 24, 2013
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular riskM Angelyn Bethel, Antonio R Chacra, Prakash Deedwania, et al.The American Journal of Medicine|June 6, 2016
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart FailureKumar Sanam, Vikas Bhatia, Navkaranbir S Bajaj, et al.Circulation. Heart Failure|December 7, 2014
Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST)Linda G Jones, Mo-Kyung Sin, Fadi G Hage, et al.The American Journal of Medicine|April 5, 2023
Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney DiseaseSamir Patel, Phillip H Lam, Evangelos I Kanonidis, et al.The American Journal of Medicine|July 13, 2016
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart FailureCherinne Arundel, Phillip H Lam, Rahul Khosla, et al.JAMA Oncology|July 28, 2022
Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not RecommendedCharles Faselis, Joel A Nations, Charity J Morgan, et al.Pageof 18